{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:09:50Z","timestamp":1770282590173,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005758","name":"Universit\u00e0 Politecnica delle Marche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.numecd.2023.08.011","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T02:26:11Z","timestamp":1692671171000},"page":"136-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy: An exploratory study"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-0181","authenticated-orcid":false,"given":"Riccardo","family":"Sarzani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Allevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Giulietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Sarnari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuele","family":"Scorcella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Di Agostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Turri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Di Pentima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Spannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2023.08.011_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.numecd.2023.08.011_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.numecd.2023.08.011_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2023.08.011_bib4","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2023.08.011_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European atherosclerosis society consensus panel statement on assessment, aetiology and management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2023.08.011_bib6","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2023.08.011_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/archinternmed.2008.552","article-title":"Continuation of statin treatment and all-cause mortality: a population-based cohort study","volume":"169","author":"Shalev","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2023.08.011_bib8","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/jgs.16060","article-title":"Statin use over 65 Years of age and all-cause mortality: a 10-year follow-up of 19 518 people","volume":"67","author":"Eilat-Tsanani","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.numecd.2023.08.011_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.numecd.2023.08.011_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amjmed.2011.08.007","article-title":"Statin use and musculoskeletal pain among adults with and without arthritis","volume":"125","author":"Buettner","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.numecd.2023.08.011_bib11","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jacl.2014.03.004","article-title":"Panel TNLAMSE. An assessment by the statin muscle safety task force: 2014 update","volume":"8","author":"Rosenson","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.numecd.2023.08.011_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10557-017-6723-4","article-title":"The statin-associated muscle symptom clinical index (SAMS-CI): revision for clinical use, content validation, and inter-rater reliability","volume":"31","author":"Rosenson","year":"2017","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.numecd.2023.08.011_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41569-018-0098-5","article-title":"Safety and efficacy of statin therapy","volume":"15","author":"Adhyaru","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2023.08.011_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.08.011_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.numecd.2023.08.011_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jcsm.12344","article-title":"Introducing the \u201cDrucebo\u201d effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions","volume":"9","author":"Penson","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.numecd.2023.08.011_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jacl.2016.05.002","article-title":"The nocebo effect in the context of statin intolerance","volume":"10","author":"Tobert","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.numecd.2023.08.011_bib18","series-title":"Pharmacological approach to smoking cessation: an updated review for daily clinical practice","author":"Giulietti","year":"2020"},{"key":"10.1016\/j.numecd.2023.08.011_bib19","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2023.08.011_bib20","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2023.08.011_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004249","article-title":"Prevalence and management of symptoms associated with statin therapy in community practice: insights from the PALM (patient and provider assessment of lipid management) registry","volume":"11","author":"Navar","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.numecd.2023.08.011_bib22","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0140-6736(17)31075-9","article-title":"Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension","volume":"389","author":"Gupta","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.numecd.2023.08.011_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta25160","article-title":"The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs","volume":"25","author":"Herrett","year":"2021","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.numecd.2023.08.011_bib24","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jacc.2021.07.022","article-title":"Side effect patterns in a crossover trial of statin, placebo, and No treatment","volume":"78","author":"Howard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2023.08.011_bib25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(22)01545-8","article-title":"Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials","volume":"400","year":"2022","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.numecd.2023.08.011_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40122-021-00235-2","article-title":"Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain","volume":"10","author":"El-Tallawy","year":"2021","journal-title":"Pain Ther"},{"key":"10.1016\/j.numecd.2023.08.011_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jpain.2021.08.007","article-title":"A clinical description of chronic pain in a general population using ICD-10 and ICD-11 (the HUNT pain examination study)","volume":"23","author":"Borchgrevink","year":"2022","journal-title":"J Pain"},{"key":"10.1016\/j.numecd.2023.08.011_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ageing\/27.3.279","article-title":"Population-based study of pain in elderly people: a descriptive survey","volume":"27","author":"Brochet","year":"1998","journal-title":"Age Ageing"},{"key":"10.1016\/j.numecd.2023.08.011_bib29","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.1532-5415.2002.50517.x","article-title":"Management of nonmalignant pain in home-dwelling older people: a population-based survey","volume":"50","author":"Pitkala","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.numecd.2023.08.011_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00002.2019","article-title":"Muscle toxicity of drugs: when drugs turn physiology into pathophysiology","volume":"100","author":"Janssen","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/j.numecd.2023.08.011_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/M17-1566","article-title":"Statin denial: an internet-driven cult with deadly consequences","volume":"167","author":"Nissen","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2023.08.011_bib32","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin safety and associated adverse events: a scientific statement from the American heart association","volume":"39","author":"Newman","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323003344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323003344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:25:41Z","timestamp":1760545541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475323003344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0939475323003344"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2023.08.011","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-reported muscle symptoms and their characterization in a hypertensive population eligible for statin therapy: An exploratory study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2023.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}]}}